Related Experiment Video
Updated: Sep 5, 2025

07:30
Rapid Nanoprobe Signal Enhancement by In Situ Gold Nanoparticle Synthesis
Published on: March 7, 2018
7.7K
Paper Biosensor for the Detection of NT-proBNP Using Silver Nanodisks as Electrochemical Labels
Yi Peng1, Nikhil Raj1, Juliette W Strasser1
1Department of Chemistry, The University of Texas at Austin, 100 E. 24th St., Stop A1590, Austin, TX 78712-1224, USA.
Nanomaterials (Basel, Switzerland)
|July 9, 2022
Summary
Silver nanodisks (AgNDs) enhance heart failure biomarker detection. This novel electrochemical labeling method offers a superior dynamic range for NT-proBNP assays, aiding in accurate risk stratification.
Area of Science:
- Nanotechnology
- Electrochemistry
- Biomarker Detection
Background:
- Heart failure diagnosis relies on biomarkers like NT-proBNP.
- Current detection methods require optimization for sensitivity and dynamic range.
- Silver nanoparticles offer potential as electrochemical labels due to their unique properties.
Purpose of the Study:
- To investigate silver nanodisks (AgNDs) as electrochemical labels for NT-proBNP detection.
- To evaluate the performance of AgNDs compared to other silver nanoparticle shapes.
- To establish the dynamic range of the AgND-based assay for heart failure risk stratification.
Main Methods:
- Synthesis of silver nanodisks (AgNDs) with specific dimensions.
- Development of a metalloimmunoassay using AgNDs as electrochemical labels.
- Detection via electrochemically activated galvanic exchange (GE) and anodic stripping voltammetry (ASV).
Main Results:
- AgNDs demonstrated a superior dynamic range compared to Ag nanocubes and nanospheres.
- The model assay showed a linear dynamic range of 1.5–30.0 pM AgNDs.
- The NT-proBNP assay achieved a dynamic range of 0.03–4.0 nM, overlapping the clinical risk stratification range.
Conclusions:
- Silver nanodisks are effective electrochemical labels for NT-proBNP detection.
- The unique GE mechanism of AgNDs contributes to improved assay performance.
- This method shows promise for sensitive and accurate heart failure risk stratification.

